Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21243335 | 0.88 | — | — | |
| SCHEMBL21243338 | 0.88 | — | — | |
| SCHEMBL21243342 | 0.86 | — | — | |
| SCHEMBL21243356 | 0.85 | LIPA (0.33) | — | |
| SCHEMBL21243381 | 0.85 | — | — | |
| SCHEMBL21243384 | 0.84 | MAPT (0.33) | LMNA | |
| SCHEMBL21243332 | 0.83 | — | — | |
| SCHEMBL21243364 | 0.78 | — | — | |
| SCHEMBL21243377 | 0.76 | — | — | |
| SCHEMBL11283030 | 0.71 | LMNA (0.46) | LMNASLC1A3SLC1A2SLC1A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | DNAH12, DYNC1LI1, DYNC1LI2 | LMNA 2553/4885SLC1A3 2125/4885SLC1A2 1903/4885 |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | DNAH12, DYNC1LI1, DYNC1LI2 | LMNA 2553/4885SLC1A3 2125/4885SLC1A2 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.